Invasive fungal infections in children with hematological malignancies: A 5-year study [2]

Pediatric Hematology and Oncology

Volumn 23, Issue 2, 2006, Pages 163-166

  Athanassiadou, Fani ^a,c   Tragiannidis, Athanassios ^a   Kourti, Maria ^a   Papageorgiou, Theodotis ^a   Velegraki, Aristea ^b   Drevelengas, Antonios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Aristotle University ^*  (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CASPOFUNGIN; CORTICOSTEROID; FLUCONAZOLE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FLAVUS; CANDIDA; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DRUG RESPONSE; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LETTER; LUNG ASPERGILLOSIS; MALE; MYCOSIS; NONHODGKIN LYMPHOMA; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MYCOSES; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 31644444374     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010500457327     Document Type: Letter

References (10)

1. Gozdasoglu S, Ertem M, Buyukkececi Z, et al. Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy. Med Pediatr Oncol. 1999;32:344-348.
2. Swu-Jane L, Schranz J, Teutsch M. Aspergillosis case-fatality rate: systemic review of the literature. Clin Infect Dis. 2001;32:358-366.
3. Grigull L, Beier R, Schrauder A, et al. Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL. Mycoses. 2003;46:441-446.
4. Chanock S. Evolving risk factors for infectious complications of cancer therapy. Hematol Oncol Clin North Am. 1993;7:771-794.
5. Gerson SL, Talbot GH, Hurwitz S, Strom B, Lusk E, Cassileth P. Prolonged neutropenia: the major risk factor for invasive pulmonary Aspergillosis in patients with acute leukemia. Ann Int Med. 100;345-351.
6. Ascioglu S, Rex JH, de Pauw B, et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14.
7. Wiley J, Smith N, Leventhal B, Graham M, Strauss L, Hurwitz C. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis. J Clin Oncol. 1990;8:280-286.
8. Anderson K, Morris G, Kennedy H, et al. Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air. Thorax. 1996;51:256-261.
9. Walsh T, Goodman J, Pappas P, et al. Safety, tolerance and pharmacokinetics of high-dose liposomal amhpotericin B in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemothe. 2001;45:3487-3496.
10. Castagnola E, Machetti M, Cappelli B, et al. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant. Clin Microbiol Infect. 2004;10:255-257.